Publications by authors named "Virginia Sutton"

Claim this Profile
G
Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
Roy H Perlis, David H Adams, Bonnie Fijal, Virginia K Sutton, Mark Farmen

J Clin Psychiatry· May 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of placebo responders in pediatric clinical trials of attention-deficit/hyperactivity disorder.
Jeffrey H Newcorn, Virginia K Sutton, Shuyu Zhang, Timothy Wilens, Christopher Kratochvil

J Am Acad Child Adolesc Psychiatry· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number needed to treat or harm analyses of olanzapine for maintenance treatment of bipolar disorder.
Mauricio Tohen, Jennifer Sniadecki, Virginia K Sutton, Elisabeth K Degenhardt, Jamie L Karagianis

J Clin Psychopharmacol· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atomoxetine for treating pediatric attention-deficit/hyperactivity disorder: comparison of morning and evening dosing.
Stan L Block, Douglas Kelsey, Daniel Coury, Donald Lewis, Humberto Quintana, Virginia Sutton

Clin Pediatr (Phila)· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and safety of the combination of fluoxetine and olanzapine in outpatients with bipolar depression: an open-label, randomized, flexible-dose study in Puerto Rico.
Jorge M Tamayo, Virginia K Sutton, Manuel A Mattei, Barbara Diaz, Hassan H Jamal

J Clin Psychopharmacol· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Maintenance of response following stabilization of mixed index episodes with olanzapine monotherapy in a randomized, double-blind, placebo-controlled study of bipolar 1 disorder.
Mauricio Tohen, Virginia K Sutton, Joseph R Calabrese, Gary S Sachs, Charles L Bowden

J Affect Disord· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in catechol-O-methyltransferase is associated with duloxetine response in a clinical trial for major depressive disorder.
Roy H Perlis, Bonnie Fijal, David H Adams, Virginia K Sutton, Madhukar H Trivedi

Biol Psychiatry· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical responses to atomoxetine in attention-deficit/hyperactivity disorder: the Integrated Data Exploratory Analysis (IDEA) study.
Jeffrey H Newcorn, Virginia K Sutton, Margaret D Weiss, Calvin R Sumner

J Am Acad Child Adolesc Psychiatry· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subjective and objective measures of sleep in children with attention-deficit/hyperactivity disorder.
Judith Owens, R Bart Sangal, Virginia K Sutton, Rosalie Bakken, Albert J Allen

Sleep Med· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Life Participation Scale for Attention-Deficit/Hyperactivity Disorder--Child Version: psychometric properties of an adaptive change instrument.
Keith Saylor, Curt Buermeyer, Virginia Sutton, Douglas Faries, Sajjad Khan

J Child Adolesc Psychopharmacol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atomoxetine treatment for pediatric patients with attention-deficit/hyperactivity disorder with comorbid anxiety disorder.
Daniel Geller, Craig Donnelly, Frank Lopez, Richard Rubin, Jeffrey Newcorn, Virginia Sutton

J Am Acad Child Adolesc Psychiatry· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life assessment in adult patients with attention-deficit/hyperactivity disorder treated with atomoxetine.
Lenard A Adler, Virginia K Sutton, Rodney J Moore, Anthony P Dietrich, Frederick W Reimherr

J Clin Psychopharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo-controlled study of the effects of atomoxetine on bladder control in children with nocturnal enuresis.
Calvin R Sumner, Kory J Schuh, Virginia K Sutton, Robert Lipetz, Douglas K Kelsey

J Child Adolesc Psychopharmacol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of atomoxetine and methylphenidate on sleep in children with ADHD.
R Bart Sangal, Judith Owens, Albert J Allen, Virginia Sutton, Kory Schuh

Sleep· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of once versus twice daily atomoxetine in adults with ADHD.
Lenard Adler, Anthony Dietrich, Fred W Reimherr, Leslie V M Taylor, Virginia K Sutton

Ann Clin Psychiatry· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment?
Charles M Beasley, Virginia K Sutton, Cindy C Taylor, Gopalan Sethuraman, Martin Dossenbach

J Clin Psychopharmacol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily atomoxetine treatment for children with attention-deficit/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial.
Douglas K Kelsey, Calvin R Sumner, Charles D Casat, Daniel L Coury, Humberto Quintana, Virginia K Sutton

Pediatrics· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, placebo-controlled trial of olanzapine in the prevention of psychotic relapse.
Charles M Beasley, Virginia K Sutton, Susan H Hamilton, Daniel J Walker, Martin Dossenbach

J Clin Psychopharmacol· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of risperidone and olanzapine in the control of negative symptoms of chronic schizophrenia and related psychotic disorders in patients aged 50 to 65 years.
Peter D Feldman, Christopher J Kaiser, John S Kennedy, Virginia K Sutton, Pierre V Tran

J Clin Psychiatry· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson's disease.
Alan Breier, Virginia K Sutton, Peter D Feldman, Deborah L Kadam, Iris Ferchland

Biol Psychiatry· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, placebo-controlled dose-response comparison of intramuscular olanzapine and haloperidol in the treatment of acute agitation in schizophrenia.
Alan Breier, Karena Meehan, Martin Birkett, Stacy David, Iris Ferchland, Virginia Sutton

Arch Gen Psychiatry· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis